Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

No new drugs? Blame Wall Street
CNN/Fortune
Monday, November 28, 2011 - 9:49am
tags:
innovation, patents, patent cliff
Medical marketing in legal battleground
Philadelphia Inquirer, PA
Sunday, November 27, 2011 - 12:10pm
tags:
legal, marketing
3 Rallying Healthcare Stocks With Bullish Short Trends
Seeking Alpha
Sunday, November 27, 2011 - 12:07pm
tags:
Biomarin, Questcor Pharmaceuticals, Medivation
Former executive sues KV Pharmaceutical
STL Today, MO
Sunday, November 27, 2011 - 12:03pm
tags:
KV Pharmaceutical, lawsuits
KV PHARMACEUTICAL DOWN 3.3%, SHARES SLIDE INTO THE RED (KV.A)
Zacks
Saturday, November 26, 2011 - 11:14am
tags:
KV Pharmaceutical
Takeda submits new drug application in the U.S. for Type 2 Diabetes Continue reading on Examiner.com Takeda submits new drug application in the U.S. for Type 2 Diabetes
Wall Street Journal
Saturday, November 26, 2011 - 11:08am
tags:
Takeda, alogliptin, metformin, diabetes
Pozen Enters into Purchase and Sale Agreement with CPPIB Credit Investments; Shares Rise 48% Pre-Market
Benzinga
Saturday, November 26, 2011 - 11:02am
tags:
Pozen
Questor Pharmaceuticals: Even In A Bad Market, Fantastic Growth Looks Attractive
Seeking Alpha
Saturday, November 26, 2011 - 11:00am
tags:
Questcor Pharmaceuticals
7 Black Friday Biotech Bargains
Motley Fool
Saturday, November 26, 2011 - 10:50am
tags:
Dendreon, Human Genome Sciences, GSK, Avanir, Exelixis, MannKind, Amarin, Vertex Pharmaceuticals
Amarin Omega-3 Medication
Investor's Business Daily
Saturday, November 26, 2011 - 10:46am
tags:
Amarin, AMR101, omega-3 fatty acid
Teva Pharmaceutical: Dividend Dynamo, or the Next Blowup?
Motley Fool
Saturday, November 26, 2011 - 10:44am
tags:
Teva Pharmaceuticals
Here's How Eli Lilly May Be Failing You
Motley Fool
Saturday, November 26, 2011 - 10:42am
tags:
Eli Lilly
My Favorite Drug Company: Teva Pharmaceuticals
Seeking Alpha
Saturday, November 26, 2011 - 10:41am
tags:
Teva Pharmaceuticals
Has Merck Become the Perfect Stock?
Motley Fool
Saturday, November 26, 2011 - 10:40am
tags:
Merck
Abbott Breakup Will Create Two Moaty Companies
Yahoo/Morningstar
Saturday, November 26, 2011 - 10:39am
tags:
Abbott Laboratories
AstraZeneca: Dirt Cheap Pharmaceutical Stock With A 6% Yield And Strong Technical Support
Seeking Alpha
Saturday, November 26, 2011 - 10:37am
tags:
AstraZeneca
Ranbaxy Gains After Report It May Get U.S. Approval for Lipitor
Bloomberg
Saturday, November 26, 2011 - 10:36am
tags:
Ranbaxy, Lipitor, generics, Pfizer
Pfizer, Bristol-Myers’ Eliquis Recommended by U.K. Cost Agency
Bloomberg
Saturday, November 26, 2011 - 10:33am
tags:
Pfizer, Bristol-Myers Squibb, Eliquis, anti-clotting
UK switches over to Merck, Sanofi HPV vaccine
Reuters
Saturday, November 26, 2011 - 10:31am
tags:
Merck, Sanofi, HPV, Gardasil, Cervarix, GSK
Medicis Reviews Purchase of Graceway Pharma
Yahoo/Zacks
Saturday, November 26, 2011 - 10:26am
tags:
Medicis, Graceway

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.